26 Feb 2026 Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA Download
12 Feb 2026 Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA Download
5 Feb 2026 Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary Download
12 Jan 2026 Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America Download
19 Dec 2025 Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone Download